Design of randomized controlled confirmatory trials using historical control data to augment sample size for concurrent controls

被引:13
|
作者
Yuan, Jiacheng [1 ]
Liu, Jeen [1 ]
Zhu, Ray [1 ]
Lu, Ying [2 ]
Palm, Ulo [3 ]
机构
[1] Allergan Pharmaceut Inc, Biostat, Irvine, CA USA
[2] Stanford Univ, Sch Med, Dept Biomed Data Sci, Stanford, CA 94305 USA
[3] Allergan Pharmaceut Inc, Drug Dev Operat, Madison, NJ USA
关键词
Historical control; matching; propensity score; randomized controlled trial; sample size; PROPENSITY-SCORE; MEDICAL LITERATURE; CRITICAL-APPRAISAL; METAANALYSIS; RECOMMENDATIONS; BIMATOPROST; TUTORIAL; TIMOLOL;
D O I
10.1080/10543406.2018.1559853
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This paper deals with the methods to augment concurrent controls (CC) in a randomized controlled trial with available historical data in clinical studies. In their article, Matching with multiple control groups and adjusting for group differences, Stuart and Rubin proposed a matching method where the primary/local control and the secondary/non-local control are both included in the propensity score estimates. The authors discuss a similar approach taking the CC as the primary and the historical control as the secondary, and find that this approach does not save the sample size of the randomized trial compared to the traditional randomized design without supplementation of historical data. A new matching method that saves sample size is proposed, where propensity scores are estimated without the concurrent randomized control patients. A two-stage design is proposed, which allows one to examine the assumption of the new matching method before a commitment of using the matching method in the second stage. Previous clinical trials data is used as an example to illustrate the feasibility of the proposed methods. Simulation studies have been used to investigate operating characteristics of the proposed method.
引用
收藏
页码:558 / 573
页数:16
相关论文
共 50 条
  • [41] Sample size requirements to estimate key design parameters from external pilot randomised controlled trials: a simulation study
    M Dawn Teare
    Munyaradzi Dimairo
    Neil Shephard
    Alex Hayman
    Amy Whitehead
    Stephen J Walters
    Trials, 15
  • [42] Sample size requirements to estimate key design parameters from external pilot randomised controlled trials: a simulation study
    Teare, M. Dawn
    Dimairo, Munyaradzi
    Shephard, Neil
    Hayman, Alex
    Whitehead, Amy
    Walters, Stephen J.
    TRIALS, 2014, 15
  • [43] Focus on Data: Statistical Design of Experiments and Sample Size Selection Using Power Analysis
    Ledolter, Johannes
    Kardon, Randy H.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (08)
  • [44] Sample size calculations for noninferiority trials for time-to-event data using the concept of proportional time
    Phadnis, Milind A.
    Mayo, Matthew S.
    JOURNAL OF APPLIED STATISTICS, 2021, 48 (06) : 1009 - 1032
  • [45] Using Quotas Constructed from Auxiliary Data to Guide the Recruitment of Sites for Randomized Controlled Trials
    Olsen, Robert B.
    Vasquez-Rossi, Maria L.
    JOURNAL OF RESEARCH ON EDUCATIONAL EFFECTIVENESS, 2024,
  • [46] Sample size considerations in active-control non-inferiority trials with binary data based on the odds ratio
    Siqueira, Arminda Lucia
    Todd, Susan
    Whitehead, Anne
    STATISTICAL METHODS IN MEDICAL RESEARCH, 2015, 24 (04) : 453 - 461
  • [47] Variations in the Design and Use of Attention Control Groups in Type 2 Diabetes Randomized Controlled Trials: a Systematic Review
    Casey A. Droske
    Triniece N. Pearson
    Sharon J. Velkovich
    Hannah Cohn
    Jacqueline M. Kanoon
    Arshiya A. Baig
    Valerie G. Press
    Current Diabetes Reports, 2023, 23 : 217 - 229
  • [48] Variations in the Design and Use of Attention Control Groups in Type 2 Diabetes Randomized Controlled Trials: a Systematic Review
    Droske, Casey A.
    Pearson, Triniece N.
    Velkovich, Sharon J.
    Cohn, Hannah
    Kanoon, Jacqueline M.
    Baig, Arshiya A.
    Press, Valerie G.
    CURRENT DIABETES REPORTS, 2023, 23 (09) : 217 - 229
  • [49] Replication of Randomized, Controlled Trials Using Real-World Data: What Could Go Wrong?
    Thompson, David
    VALUE IN HEALTH, 2021, 24 (01) : 112 - 115
  • [50] Randomized controlled trials in non-pharmacological rehabilitation research: a scoping review of the reporting of sample size calculation, randomization procedure, and statistical analyses
    Amiri, Mohammadreza
    Kumbhare, Dinesh
    EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE, 2020, 56 (06) : 790 - 798